June 11, 2024 – Page 4 – Goldea Capital

KPN successfully issues € 500m Green Hybrid Bond

Written by Customer Service on June 11, 2024. Posted in Public Companies.

NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT Today, Koninklijke KPN N.V. (“KPN”) has successfully issued a Green € 500m perpetual non-call 5.25 year subordinated bond to finance projects that support KPN’s sustainability ambitions and have a positive environmental impact (the “Green Hybrid Bond”). With this issuance, KPN further demonstrates its commitment to its sustainability ambitions through financing arrangements. The Green Hybrid Bond issuance has been well received by institutional investors with a final orderbook in excess of € 1.9bn and a broad diversified investor base. The Green Hybrid Bond was priced with a coupon of 4.875% per annum until the first reset date on 18 September 2029 and is first...

HEALWELL AI to Acquire VeroSource Solutions and its Cloud-based Health Data Interoperability Platform to Help Large Enterprises Adopt AI-Powered Population Health Capabilities

Written by Customer Service on June 11, 2024. Posted in Mergers And Acquisitions.

HEALWELL enters into an agreement to acquire VeroSource Solutions Inc. and its end-to-end, customizable, cloud-based platform that enables patients, care providers and administrators to seamlessly access and interact with healthcare data. VeroSource currently serves five provincial health clients and is expected to generate over $8 million in revenues in 2024 with an expected EBITDA1 margin of over 10%. Historically, VeroSource has achieved a 3-year revenue CAGR2 of 30% and higher than 80% gross margins and has consistently produced positive EBITDA1 and cashflows. Over 70% of its sales are recurring revenue. The transaction is expected to be financially and strategically accretive as VeroSource provides data products, insights and services to large enterprises such as Canadian provincial healthcare systems. VeroSource’s products are expected...

Azuria Announces Acquisition of Infrastructure Services Group LLC and Subsidiaries

Written by Customer Service on June 11, 2024. Posted in Mergers And Acquisitions.

The North American Leader in Technology-Enabled Water Solutions Welcomes ISG Partner Companies Mr. Rehab LLC, Green Mountain Pipeline Services LLC and Inland Waters LLC to its Portfolio ST. LOUIS, June 11, 2024 (GLOBE NEWSWIRE) — Azuria Corporation, a leading provider of infrastructure maintenance, rehabilitation and technology-enabled water solutions, today announced the acquisition of Infrastructure Services Group (ISG) LLC, a firm that acquires and funds private companies that specialize in inspection, repair and rehabilitation of water and wastewater infrastructure systems. The acquisition includes the purchase of ISG partner companies, including Mr. Rehab, Green Mountain Pipeline Services, and Inland Waters. “Azuria has enjoyed a long relationship with Mr. Rehab, Green Mountain and Inland Waters,” said Rob Tullman, President...

Pender Growth Fund Portfolio Company Announces Proposed Transaction

Written by Customer Service on June 11, 2024. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) — (TSXV: PTF) Pender Growth Fund Inc. (the “Company” or “PTF”) today announces that one of its significant investees, Copperleaf Technologies Inc. (TSX:CPLF) (“Copperleaf”), has entered into a definitive arrangement agreement (the “Arrangement Agreement”) with Industrial and Financial Systems, IFS AB (“IFS”), pursuant to which IFS has agreed to indirectly acquire all of the issued and outstanding common shares of Copperleaf (the “Copperleaf Shares”) for $12.00 in cash per Copperleaf Share (the “Copperleaf Transaction”). The Company owns 6,739,883 Copperleaf Shares and its NAV as at May 31, 2024 was $11.9164 per common share based on a price per Copperleaf Share of $8.30 and based on its 7,286,129 shares outstanding. The Company is subject to a 15% performance fee on gains...

SEALSQ to Launch Two New Quantum Resistant Chips

Written by Customer Service on June 11, 2024. Posted in Public Companies.

The QS7001 and QVault TPM are expected to launch as early as Q4 2024 Geneva, Switzerland, June 11, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that the launch of its new range of Quantum Resistant, or Post Quantum Secure Chips, the QS7001 and QVault TPM, is planned for as early as Q4 2024. The Company’s investments and focus on the QUASARs post-quantum project have enabled the engineering team to progress rapidly on the development roadmap. Following the design phase and production and test of the first proof-of-concept, the QS7001 engineering samples are being produced and expected to be ready to order as soon as the fourth quarter...

Form 8.3 – [LOK’N STORE GROUP PLC – 10 06 2024] – (CGAML)

Written by Customer Service on June 11, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LOK’N STORE GROUP PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e) Date...

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway

Written by Customer Service on June 11, 2024. Posted in Public Companies.

–FDA Grants Pre-BLA Meeting Request and Rolling BLA Submission after Review of HOPE-2 and HOPE-2 OLE 3-Year Results– SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA) on next steps for the Biologics License Application (BLA) submission with its lead asset, CAP-1002 for the treatment of Duchenne muscular dystrophy (DMD). Additionally, Deramiocel has been selected as the proposed International Nonproprietary Name (INN) for CAP-1002 by the World Health Organization. “The last year has been transformative for Capricor as we have moved rapidly towards potential...

The State of Massachusetts Issues MOR-EV Approval, Granting Mullen’s Class 3 EV Truck a $15,000 Cash Voucher per Vehicle Sold

Written by Customer Service on June 11, 2024. Posted in Public Companies.

Massachusetts Approves $15,000 Cash Voucher Incentive for Mullen THREE EV Truck MOR-EV program is funded by the MA Executive Office of Energy and Environmental Affairs’ Department of Energy Resources (DOER) and administered statewide by the Center for Sustainable Energy (CSE). Under the MOR-EV program, the Mullen THREE EV truck, with a suggested MSRP of $68,500, now qualifies for a Massachusetts state cash rebate of up to $15,000 When combined with the available $7,500 federal tax credit, the net effective price of the Mullen THREE would be approximately $46,000 BREA, Calif., June 11, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announces today the Massachusetts Executive Office of Energy and Environmental Affairs’ Department...

Orocidin – New Insights Into The Treatment Of Periodontitis

Written by Customer Service on June 11, 2024. Posted in Public Companies.

Beverly Hills, California., June 11, 2024 (GLOBE NEWSWIRE) — Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, and its 95% owned subsidiary, Orocidin A/S (“Orocidin”), announced today new insights into the treatment of periodontitis. Orocidin’s preclinical product is called QR-01 and has a novel mode of action. It will be the first ever medical treatment of periodontitis reaching the dental market. The main problem with periodontitis is to treat bacterial infection as well as normalize the immunological function. This concern has highlighted the pressing need for the development of new treatment modalities. OR-01 is specifically designed to...

Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award

Written by Customer Service on June 11, 2024. Posted in Public Companies.

Empowering healthcare and life science organizations with faster insights through seamless data sharing FRAMINGHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has been named the 2024 Databricks Healthcare and Life Sciences Partner of the Year. This prestigious award recognizes Definitive Healthcare’s exceptional collaboration with Databricks in delivering innovative data and AI solutions to the healthcare and life sciences industry. “We are incredibly honored to be recognized by Databricks as their Healthcare and Life Sciences Partner of the Year,” said Casey Eastlack, AVP, Professional Services at Definitive Healthcare. “Our partnership with Databricks enables our shared customers to gain deeper and faster healthcare...

Day: June 11, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice